A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Clinical trial NCT04944992 · COMPLETED

Trial details

NCT number: NCT04944992
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis

Start date: 2021-08-04
Primary completion: 2022-10-19
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.